Results 21 to 30 of about 31,035,859 (287)

Fabrication of Microfluidic Tesla Valve Employing Femtosecond Bursts

open access: yesMicromachines, 2022
Expansion of the microfluidics field dictates the necessity to constantly improve technologies used to produce such systems. One of the approaches which are used more and more is femtosecond (fs) direct laser writing (DLW).
Deividas Andriukaitis   +9 more
doaj   +1 more source

Public Act 098-0295 or the Open Access to Research Articles Act Findings and Recommendations [PDF]

open access: yes, 2014
Final report containing the findings and recommendations of Governors State University\u27s Open Access Task Force in compliance with Public Act 098 ...
Open Access Task Force
core   +1 more source

Huddersfield Open Access Publishing [PDF]

open access: yes, 2011
This paper presents the findings of the Huddersfield Open Access Publishing Project, a JISC funded project to develop a low cost, sustainable Open Access (OA) journal publishing platform using EPrints Institutional Repository ...
Graham Stone, Stone, Graham
core   +1 more source

A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project

open access: yesBMC Psychiatry, 2019
Background Many Canadian adolescents and young adults with mental health problems face delayed detection, long waiting lists, poorly accessible services, care of inconsistent quality and abrupt or absent inter-service transitions. To address these issues,
Srividya N. Iyer   +20 more
doaj   +1 more source

When Is Open Access Not Open Access?

open access: yesPLoS Biology, 2007
As open access grows in prominence, so too has confusion about what open access means; such confusion arises from a genuine misunderstanding of open access by funders, authors, editors, and publishers alike.
openaire   +4 more sources

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis

open access: yesDermatology and Therapy, 2023
Introduction Deucravacitinib, an oral tyrosine kinase 2 (TYK2) inhibitor, is approved in the United States to treat adults with moderate-to-severe plaque psoriasis (PsO).
April W. Armstrong   +6 more
doaj   +1 more source

Empfehlungen zur Open-Access-Transformation

open access: yes, 2016
Die vorliegenden „Empfehlungen zur Open-Access-Transformation“ wurden von der Ad-hoc-Arbeitsgruppe „Open-Access-Gold“ im Rahmen der Schwerpunktinitiative „Digitale Information“ der Allianz der deutschen Wissenschaftsorganisationen erarbeitet und basieren
Hanig, Kristina   +10 more
core   +1 more source

Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials.

open access: yesPLoS ONE, 2020
Patients' vitamin intake is often not documented and is therefore not considered sufficiently in studies of prescribed medication in patients with amyotrophic lateral sclerosis (ALS). We aimed to determine the prevalence of vitamin use by participants in
Tino Prell   +2 more
doaj   +1 more source

Open Access für Forschung und Kultur – Die Staatsbibliothek zu Berlin unterstützt den offenen Zugang zu wissenschaftlichem Wissen

open access: yes, 2016
Seit ihrer Gründung im Jahr 1661 ist die Staatsbibliothek zu Berlin (SBB) für die Öffentlichkeit zugänglich. In dieser Tradition sowie im Bewusstsein ihrer besonderen historischen Verantwortung steht die SBB zu ihrer Verpflichtung, wissenschaftliches ...
Staatsbibliothek zu Berlin (5295346)   +1 more
core   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy